cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo
Open Access
- 20 May 2008
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (20), 7281-7286
- https://doi.org/10.1073/pnas.0711190105
Abstract
Tissue engineering of large bone defects is approached through implantation of autologous osteogenic cells, generally referred to as multipotent stromal cells or mesenchymal stem cells (MSCs). Animal-derived MSCs successfully bridge large bone defects, but models for ectopic bone formation as well as recent clinical trials demonstrate that bone formation by human MSCs (hMSCs) is inadequate. The expansion phase presents an attractive window to direct hMSCs by pharmacological manipulation, even though no profound effect on bone formation in vivo has been described so far using this approach. We report that activation of protein kinase A elicits an immediate response through induction of genes such as ID2 and FosB, followed by sustained secretion of bone-related cytokines such as BMP-2, IGF-1, and IL-11. As a consequence, PKA activation results in robust in vivo bone formation by hMSCs derived from orthopedic patients.Keywords
This publication has 44 references indexed in Scilit:
- The Response of Human Mesenchymal Stem Cells to Osteogenic Signals and its Impact on Bone Tissue EngineeringCurrent Stem Cell Research & Therapy, 2007
- A Rapid and Efficient Method for Expansion of Human Mesenchymal Stem CellsTissue Engineering, 2007
- Inhibition of Histone Acetylation as a Tool in Bone Tissue EngineeringTissue Engineering, 2006
- A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: In vivo bone formation showing proof of conceptBiomaterials, 2006
- Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle DegenerationScience, 2005
- Parathyroid hormone-related peptide (PTHrP) inhibits Runx2 expression through the PKA signaling pathwayExperimental Cell Research, 2004
- Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cellsNature Biotechnology, 2002
- Tissue-engineered bone regenerationNature Biotechnology, 2000
- Adult Human Mesenchymal Stem Cell Differentiation to the Osteogenic or Adipogenic Lineage Is Regulated by Mitogen-activated Protein KinasePublished by Elsevier BV ,2000
- cAMP Stimulates Osteoblast-like Differentiation of Calcifying Vascular CellsPublished by Elsevier BV ,1998